Answers are grounded in this paper and cite their sources.
Diabetic foot ulcers (DFUs) are a common complication of diabetes mellitus and can lead to serious problems such as slow wound healing, persistent infection and amputation of the lower limb. Treatment is difficult because recovery can be hindered by a number of conditions such as poor blood circulation, peripheral neuropathy, poor wound healing and antibiotic resistance. Biofilms may also play a role in the ability of bacteria to persist in chronic wounds. This could make the body's immune system and antimicrobial drugs more tolerant of bacteria that form in biofilms, making it harder to manage infections. However, classical antimicrobial resistance and tolerance associated with biofilms are different mechanisms and should be treated separately. This review highlights the common bacteria responsible for diabetic foot infections, pathophysiology and risk factors of diabetic foot ulcers and the role of biofilms in chronic wounds. It also discusses antibiotic resistance, biofilm detection methods and how these may relate to clinical outcomes including amputation, recurrent infection and delayed healing. The review additionally emphasises the drawbacks of modern diagnostic techniques, and the difficulty of comparing findings from studies using different methodologies. Standardised methods for detection of biofilm need to be established. More prospective clinical studies need to be carried out and whether biofilm results and antibiotic resistance can accurately predict treatment outcomes needs to be established. A better understanding of these variables may facilitate improved diagnosis, appropriate antibiotic selection, and more successful treatment of diabetic foot infections.
No takes yet. Share an insight, caveat, or question.
Dohale et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: